Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Interest Expenses (2019 - 2025)

Historic Interest Expenses for Precision Biosciences (DTIL) over the last 6 years, with Q3 2025 value amounting to $362000.0.

  • Precision Biosciences' Interest Expenses rose 4140.62% to $362000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 2554.6%. This contributed to the annual value of $1.8 million for FY2024, which is 2008.97% down from last year.
  • Latest data reveals that Precision Biosciences reported Interest Expenses of $362000.0 as of Q3 2025, which was up 4140.62% from $358000.0 recorded in Q2 2025.
  • Over the past 5 years, Precision Biosciences' Interest Expenses peaked at $579000.0 during Q4 2023, and registered a low of $24000.0 during Q2 2021.
  • Its 5-year average for Interest Expenses is $351611.1, with a median of $377000.0 in 2024.
  • In the last 5 years, Precision Biosciences' Interest Expenses soared by 114285.71% in 2023 and then crashed by 5555.56% in 2024.
  • Quarter analysis of 5 years shows Precision Biosciences' Interest Expenses stood at $53000.0 in 2021, then soared by 816.98% to $486000.0 in 2022, then rose by 19.14% to $579000.0 in 2023, then crashed by 32.3% to $392000.0 in 2024, then fell by 7.65% to $362000.0 in 2025.
  • Its last three reported values are $362000.0 in Q3 2025, $358000.0 for Q2 2025, and $354000.0 during Q1 2025.